A specific inhibitor of heat-shock protein 32 (HSP32) and heme oxygenase-1 (HO-1), zinc protoporphyrin IX (ZnPPIX), has also shown potential effects against breast cancer growth through HO-1 inhibition in vitro and in vivo. The gene discussed is HMOX1; the disease is breast carcinoma.